TNF and sarcoma: An exception is the use of local TNF administered locally by isolated limb perfusion treatments in melanoma and sarcoma [47], or in isolated hepatic perfusion for treatment of liver metastasis [49] which have demonstrated that TNF alone or in combination to cause large response rates of up to 80%.